Frizzell, Norma
- University of South Carolina at Columbia · Pharmacology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #26,561
- R01 Holder
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2013 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pharmacology
NIH Funding · FY2023
Linked Award Amount
$447K
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#26,561
By linked amount among FY2023 PIs
Earliest Year Loaded
2013
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Frizzell, Norma as a PI. Multi-PI records show the full award amount for context.
- 5R01NS126851-02R01Contact PIInvestigating Citric Acid Cycle Perturbations in Complex I Deficient Mitochondrial EncephalopathyUniversity of South Carolina at Columbia · Pharmacology (NIH department code)$372.5Kaward amount
- 1R03NS128819-01A1R03Contact PIDeveloping Tools to Understand an Alternative Fate of Urate in Neurodegenerative DiseasesUniversity of South Carolina at Columbia · Pharmacology (NIH department code)$74.5Kaward amount
Award organization
Organizations that administered FY2023 awards listing Frizzell, Norma as a PI.
FY2023 award administered by University of South Carolina at Columbia (SC).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2013First NIH AwardUniversity of South Carolina at Columbia
- 2015$500K Cumulative Funding
- 2015R01 Grant Holder
- 2017$1M Cumulative Funding
- 2023$2M Cumulative Funding